News & Analysis as of

Unfair or Deceptive Trade Practices Pharmaceutical Industry Rulemaking Process

Foley Hoag LLP

HHS and FDA Attempt to Crackdown on Deceptive DTC Rx Drug Advertising Following Presidential Memo

Foley Hoag LLP on

Key Takeaways: On September 9, 2025, the U.S. Department of Health and Human Services (HHS) and Food and Drug Administration (FDA) announced an effort to crack down on deceptive advertising. An accompanying Presidential...more

1 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide